Dr. László Czirják

ISN Contributing Author, Voices of Scleroderma Volume 3

Hungary

Dr. László Czirják is Professor of Rheumatology and Medicine and Head of the Department of Immunology and Rheumatology, University of Pécs, Pécs, Hungary. His article on Scleroderma-Like Disorders is featured in Chapter 1 of the ISN's book, Voices of Scleroderma Volume 3.

Author of more than 100 scientific publications, his main field of interest is the clinical, epidemiological, and immunological aspects of scleroderma. He is also actively involved in the organization of care of scleroderma patients in his country and in Europe. Besides, his department is also involved in the treatment of patients with lupus, myositis, vasculitis and Sjogren's syndrome.

Dr. László Czirják is currently a board member of the EULAR Scleroderma Trial and Research Group (EUSTAR), and vice president of the Society of the Hungarian Rheumatologists. He is also the head of the Hungarian National Board of Clinical Immunology and Allergology.

Dr. László Czirják, M.D., PhD
University of Pécs
Department of Immunology and Rheumatology, Irgalmasok u. 1. H-7621 Pécs, Hungary
Phone: 336 72 507 359
Fax: +36 72 507 359

Related Links

Dr. László Czirják: ISN Contributing Author, Voices of Scleroderma

Dr. László Czirják is Professor of Rheumatology and Medicine and Head of the Department of Immunology and Rheumatology, University of Pécs, Pécs, Hungary. His article on Scleroderma-Like Disorders is featured in Chapter 1 of the ISN's book, Voices of Scleroderma Volume 3. Posted 02-09-06.

Finding a Scleroderma Expert. International Scleroderma Network.

Juvenile Systemic Sclerosis: A Follow-up Study of Eight Patients. Our results suggest that in jSSc, Raynaud's phenomenon is more severe, whereas internal organ manifestations and the frequency of autoantibodies are far less pronounced than in adult-onset SSc. Also, the survival rate and final outcome of patients with jSSc appear to be better than those in patients with adult-onset SSc. PubMed, Ann N Y Acad Sci. 2005 Jun;1051:229-34. (Also see Juvenile Scleroderma)

SCLERO.ORG is the world's leading nonprofit for trustworthy research, support, education and awareness for scleroderma and related illnesses. We are a 501(c)(3) U.S.-based public charitable foundation, established in 2002. Meet Our Team. Donations may also be mailed to: